olmesartan medoxomil + hydrochlorothiazide

DRUG2 trials

Sponsors

Jichi Medical University, Daiichi Sankyo

Conditions

Essential HypertensionHypertension

Phase 3

Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension

CompletedNCT00872586

Daiichi SankyoEssential Hypertension

Start: 2006-08-31End: 2007-08-31Updated: 2010-09-29

Phase 4

The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)

CompletedNCT00607035

Jichi Medical UniversityHypertension

Start: 2006-05-31End: 2008-05-31Updated: 2008-11-20